000 01630 a2200457 4500
005 20250517101951.0
264 0 _c20170712
008 201707s 0 0 eng d
022 _a1932-6203
024 7 _a10.1371/journal.pone.0157830
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVeluchamy, John Pradeep
245 0 0 _aCombination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer.
_h[electronic resource]
260 _bPloS one
_c2016
300 _ae0157830 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntibodies, Monoclonal, Humanized
_xadministration & dosage
650 0 4 _aCaco-2 Cells
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell- and Tissue-Based Therapy
650 0 4 _aCetuximab
_xadministration & dosage
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aHT29 Cells
650 0 4 _aHumans
650 0 4 _aImmunoglobulin G
_ximmunology
650 0 4 _aKiller Cells, Natural
650 0 4 _aMutation
650 0 4 _aNeoplasm Metastasis
650 0 4 _aProto-Oncogene Proteins B-raf
_xgenetics
650 0 4 _aras Proteins
_xgenetics
700 1 _aSpanholtz, Jan
700 1 _aTordoir, Marleen
700 1 _aThijssen, Victor L
700 1 _aHeideman, Daniƫlle A M
700 1 _aVerheul, Henk M W
700 1 _ade Gruijl, Tanja D
700 1 _avan der Vliet, Hans J
773 0 _tPloS one
_gvol. 11
_gno. 6
_gp. e0157830
856 4 0 _uhttps://doi.org/10.1371/journal.pone.0157830
_zAvailable from publisher's website
999 _c26134552
_d26134552